{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T21:43:19Z","timestamp":1747172599067,"version":"3.40.5"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.ygyno.2015.01.539","type":"journal-article","created":{"date-parts":[[2015,1,22]],"date-time":"2015-01-22T13:20:26Z","timestamp":1421932826000},"page":"77-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Assessment of published models and prognostic variables in epithelial ovarian cancer at Mayo Clinic"],"prefix":"10.1016","volume":"137","author":[{"given":"Andrea E.","family":"Wahner Hendrickson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kieran M.","family":"Hawthorne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen L.","family":"Goode","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly R.","family":"Kalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krista M.","family":"Goergen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie N.","family":"Bakkum-Gamez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William A.","family":"Cliby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary L.","family":"Keeney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel W.","family":"Visscher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaman","family":"Tarabishy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann L.","family":"Oberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn C.","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1867-0526","authenticated-orcid":false,"given":"Matthew J.","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2015.01.539_bb0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J. Clin."},{"issue":"Suppl. 5","key":"10.1016\/j.ygyno.2015.01.539_bb0010","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1634\/theoncologist.7-suppl_5-20","article-title":"Relapsed ovarian cancer: challenges and management strategies for a chronic disease","volume":"7","author":"Armstrong","year":"2002","journal-title":"Oncologist"},{"key":"10.1016\/j.ygyno.2015.01.539_bb0015","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s11912-006-0074-9","article-title":"The current treatment of recurrent ovarian cancer","volume":"8","author":"Herzog","year":"2006","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.ygyno.2015.01.539_bb0020","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1054\/bjoc.2001.2030","article-title":"A prognostic model for ovarian cancer","volume":"85","author":"Clark","year":"2001","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2015.01.539_bb0025","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ygyno.2011.12.423","article-title":"Nomogram for predicting 5-year disease-specific mortality after primary surgery for epithelial ovarian cancer","volume":"125","author":"Barlin","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.01.539_bb0030","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1200\/JCO.2007.11.0114","article-title":"PIEPOC: a new prognostic index for advanced epithelial ovarian cancer\u2014Japan Multinational Trial Organization OC01-01","volume":"25","author":"Teramukai","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2015.01.539_bb0035","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ygyno.2007.09.020","article-title":"Nomogram for survival after primary surgery for bulky stage IIIC ovarian carcinoma","volume":"108","author":"Chi","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.01.539_bb0040","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1471-0528.2008.02033.x","article-title":"The prediction of progression-free and overall survival in women with an advanced stage of epithelial ovarian carcinoma","volume":"116","author":"Gerestein","year":"2009","journal-title":"BJOG"},{"key":"10.1016\/j.ygyno.2015.01.539_bb0045","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/bjc.2013.717","article-title":"External validation of three prognostic models for overall survival in patients with advanced-stage epithelial ovarian cancer","volume":"110","author":"van de Laar","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2015.01.539_bb0050","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ygyno.2014.07.099","article-title":"Development and internal validation of a prognostic model for survival after debulking surgery for epithelial ovarian cancer","volume":"135","author":"Rutten","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.01.539_bb0055","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nrclinonc.2013.5","article-title":"Latest research and treatment of advanced-stage epithelial ovarian cancer","volume":"10","author":"Coleman","year":"2013","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2015.01.539_bb0060","doi-asserted-by":"crossref","first-page":"5669","DOI":"10.1200\/JCO.2007.14.2976","article-title":"Validation of a new prognostic index for advanced epithelial ovarian cancer: results from its application to a UK-based cohort","volume":"25","author":"Clark","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2015.01.539_bb0065","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1158\/1078-0432.CCR-09-2553","article-title":"Inherited determinants of ovarian cancer survival","volume":"16","author":"Goode","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"676","key":"10.1016\/j.ygyno.2015.01.539_bb0070","first-page":"e1","article-title":"Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer","volume":"197","author":"Aletti","year":"2007","journal-title":"Am. J. Obstet. Gynecol."},{"year":"2001","series-title":"Regression Modeling Strategies: With applications to Linear Models, Logistic Regresion and Survival Analysis","author":"Harrell","key":"10.1016\/j.ygyno.2015.01.539_bb0080"},{"key":"10.1016\/j.ygyno.2015.01.539_bb0085","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1200\/JCO.2003.02.153","article-title":"Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study","volume":"21","author":"Ozols","year":"2003","journal-title":"J. Clin. Oncol."},{"author":"Whitney CW","key":"10.1016\/j.ygyno.2015.01.539_bb0090"},{"key":"10.1016\/j.ygyno.2015.01.539_bb0095","first-page":"101","article-title":"Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma","volume":"42","author":"Griffiths","year":"1975","journal-title":"Natl. Cancer Inst. Monogr."},{"key":"10.1016\/j.ygyno.2015.01.539_bb0100","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis","volume":"20","author":"Bristow","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2015.01.539_bb0105","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cncr.24149","article-title":"Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials","volume":"115","author":"du Bois","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2015.01.539_bb0110","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jamcollsurg.2009.01.006","article-title":"Quality improvement in the surgical approach to advanced ovarian cancer: the Mayo Clinic experience","volume":"208","author":"Aletti","year":"2009","journal-title":"J. Am. Coll. Surg."},{"key":"10.1016\/j.ygyno.2015.01.539_bb0115","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ygyno.2009.03.018","article-title":"Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm","volume":"114","author":"Chi","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.01.539_bb0120","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(08)60167-1","article-title":"Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls","volume":"371","author":"Beral","year":"2008","journal-title":"Lancet"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082581500582X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082581500582X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T00:29:12Z","timestamp":1537921752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009082581500582X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S009082581500582X"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.01.539","relation":{},"ISSN":["0090-8258"],"issn-type":[{"type":"print","value":"0090-8258"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of published models and prognostic variables in epithelial ovarian cancer at Mayo Clinic","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.01.539","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}